Fosdenopterin | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fosdenopterin
U.S. EXCLUSIVITIES

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Fosdenopterin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 NDC API

1 NDC API

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

DIGITAL CONTENT

12 NEWS #PharmaBuzz

12 NEWS #PharmaBuzz

PATENTS & EXCLUSIVITIES

1 US Patents, 3 US Exclusivities

1 US Patents
3 US Exclusivities

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

3 All

01 3SENTYNL THERAPS INC

filter Product Reset all filters

3 All

01 3FOSDENOPTERIN HYDROBROMIDE

filter Exclusivity Expiration Date Reset all filters

3 All

01 12025-10-27

02 12026-02-26

03 12028-02-26

filter Exclusivity Code Reset all filters

3 All

01 1M-286

02 1NCE

03 1ODE-342

Product Main Page

SENTYNL THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FOSDENOPTERIN HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-286

Exclusivity Expiration Date

2025-10-27

Application Number

214018

Product Number

1

Exclusivity Details

01

SENTYNL THERAPS INC

FOSDENOPTERIN HYDROBROMIDE

2024 ACI Convention

Not Confirmed

SENTYNL THERAPS INC

India

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FOSDENOPTERIN HYDROBROMIDE

Exclusivity Code : M-286

Exclusivity Expiration Date : 2025-10-27

Application Number : 214018

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

SENTYNL THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FOSDENOPTERIN HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2026-02-26

Application Number

214018

Product Number

1

Exclusivity Details

02

SENTYNL THERAPS INC

FOSDENOPTERIN HYDROBROMIDE

2024 ACI Convention

Not Confirmed

SENTYNL THERAPS INC

India

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FOSDENOPTERIN HYDROBROMIDE

Exclusivity Code : NCE

Exclusivity Expiration Date : 2026-02-26

Application Number : 214018

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

SENTYNL THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

FOSDENOPTERIN HYDROBROMIDE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-342

Exclusivity Expiration Date

2028-02-26

Application Number

214018

Product Number

1

Exclusivity Details

03

SENTYNL THERAPS INC

FOSDENOPTERIN HYDROBROMIDE

2024 ACI Convention

Not Confirmed

SENTYNL THERAPS INC

India

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

FOSDENOPTERIN HYDROBROMIDE

Exclusivity Code : ODE-342

Exclusivity Expiration Date : 2028-02-26

Application Number : 214018

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?